Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

OPC-6535 enters two pivotal trials in ulcerative colitis

July 25, 2003

Axcan acquires license to drug for treatment of hepatic encephalopathy

July 25, 2003

Kyorin and Nisshin Pharma patent new mu opioid receptor antagonists

July 22, 2003

JT researchers present new edg5 antagonists with antifibrotic activity

July 22, 2003

New European label for Pegasys reflects new genotype data

July 22, 2003

HCV-371 has no impact on HCV RNA levels in phase Ib study

July 17, 2003

Santarus completes phase III patient enrollment in upper GI bleeding prevention trial

July 17, 2003

Plant extract with gastric antisecretory activity patented by Korean researchers

July 16, 2003

Wyeth claims three series of ERbeta-selective estrogenic agents for arthritis, IBD, etc.

July 16, 2003

Genmab expands pipeline with hepatitis antibody

July 15, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...